Decitabine can be safely reduced after achievement of best objective response in patients with myelodysplastic syndrome

Hady Ghanem, A. Megan Cornelison, Guillermo Garcia-Manero, Hagop Kantarjian, Farhad Ravandi, Tapan Kadia, Jorge Cortes, Susan O'Brien, Mark Brandt, Gautam Borthakur, Elias Jabbour

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Decitabine can be safely reduced after achievement of best objective response in patients with myelodysplastic syndrome'. Together they form a unique fingerprint.

Medicine & Life Sciences